---
title: "板塊更新：醫療保健股在週一下午下跌"
description: "醫療保健股票在週一下跌，紐約證券交易所醫療保健指數下跌 0.5%，醫療保健精選行業 SPDR 基金（XLV）下跌 0.1%。諾和諾德公司的股票因其減肥藥的試驗結果令人失望而下跌 9%。相比之下，Checkpoint Therapeutics 的股票在宣佈被 Sun Pharmaceutical 收購後飆升近 62%。BioNTech 的股票在報告第四季度收入下降並預測 2025 年銷售進一步下降後"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/231259350.md"
published_at: "2025-03-10T18:02:51.000Z"
---

# 板塊更新：醫療保健股在週一下午下跌

> 醫療保健股票在週一下跌，紐約證券交易所醫療保健指數下跌 0.5%，醫療保健精選行業 SPDR 基金（XLV）下跌 0.1%。諾和諾德公司的股票因其減肥藥的試驗結果令人失望而下跌 9%。相比之下，Checkpoint Therapeutics 的股票在宣佈被 Sun Pharmaceutical 收購後飆升近 62%。BioNTech 的股票在報告第四季度收入下降並預測 2025 年銷售進一步下降後下跌 2.6%

週一下午，醫療保健類股票下跌，紐約證券交易所醫療保健指數下跌 0.5%，醫療保健精選行業 SPDR 基金（XLV）下跌 0.1%。

iShares 生物技術 ETF（IBB）下跌 0.1%。

在企業新聞方面，諾和諾德公司的股票在丹麥製藥公司最新的減肥藥物 CagriSema 的試驗結果未達到其初步預期後下跌了 9%。

Checkpoint Therapeutics 的股票上漲近 62%，該公司與印度的 Sun Pharmaceutical 在週日表示，Checkpoint 已同意以每股 4.10 美元的現金加上不可轉讓的或有價值權被 Sun 收購。

BioNTech 報告第四季度收入下降，並預計 2025 年全年銷售將再次下滑。其股票下跌 2.6%。

### Related Stocks

- [BNTX.US - BioNTech](https://longbridge.com/zh-HK/quote/BNTX.US.md)
- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Puzo Michael J Has $320,000 Stock Position in Novo Nordisk A/S $NVO | Puzo Michael J significantly reduced its stake in Novo Nordisk A/S (NYSE:NVO) by 86.9% in Q3, now holding 5,775 shares v | [Link](https://longbridge.com/zh-HK/news/276447697.md) |
| Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | Novo Nordisk board proposes re-election of Lars Rebien Sorensen as chair | [Link](https://longbridge.com/zh-HK/news/276440991.md) |
| GLP-1 Anti-Obesity U.S. Drug Market In Four Charts | UBS analysts, led by Matthew Weston, have analyzed trends in the U.S. GLP-1 anti-obesity drug market, focusing on new-to | [Link](https://longbridge.com/zh-HK/news/276280378.md) |
| Novo Nordisk Proposes Two Additional New Board Appointments | Danish pharmaceutical company Novo Nordisk is proposing three new appointments to its board of directors for the annual  | [Link](https://longbridge.com/zh-HK/news/276442777.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/zh-HK/news/275761183.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
